Objective Infection is a major complication in vascular stents. Stents
impregnated with gelatine and dipped in Rifampicin have been shown to
resist methicillin-resistant Staphylococcus aureus in both animal exp
eriments and in man. It has been suggested that ail aorto-ilio-femoral
stents should be treated. To evaluate this method, we reassessed all
stent infections observed in our patients who had undergone revascular
ization of the lower limbs from January 1985 to 1994. We excluded sten
ts implanted for ruptured aneurysms or implanted in patients with a pa
st history of local infection on vascular stents. Results The rate of
septic complications observed during the first year was 1 % for all pa
tients in the series, 0 % for aorto-aortic and aorto-biiliac stents an
d 0.7 % for aorto- bifemoral stents. These rates are similar to those
reported in the multicentric study directed by Goeau Brissoniere using
antibiotic impregnated stents. The extra cost involved in using such
stents for aorto-ilio-femoral revascularization was estimated in this
series at 2,180,000 Francs. The costs resulting from the three infecti
ons was estimated at 960,000 Francs. Conclusion Based on the findings
in this series, antibiotic impregnated stents should be indicated only
in selected patients due to the extra cost : past history of local in
fection, ruptured aneurysms, femoro-tibial stents, cross or axillo-fem
oral revascularization for which the rate of stent infection is 6,3 -
3,2 and 1.4 %, immunodeficient patients, multiple reoperations, post-i
rradiation arteritis and situations known to involve major risk of inf
ection.